Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease

Alessia Bellotti, Roberta Noseda, Roberto Masciullo, Claudio Staedler, Claudio Gobbi, Chiara Zecca

Open source

DOI
10.1007/s00415-026-14099-z
Published
2026-09-15
Container
Journal of Neurology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00415-026-14099-z,
  title = {Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease},
  author = {Alessia Bellotti and Roberta Noseda and Roberto Masciullo and Claudio Staedler and Claudio Gobbi and Chiara Zecca},
  year = {2026},
  journal = {Journal of Neurology},
  doi = {10.1007/s00415-026-14099-z},
  url = {https://doi.org/10.1007/s00415-026-14099-z}
}

RIS

TY  - JOUR
TI  - Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease
AU  - Alessia Bellotti
AU  - Roberta Noseda
AU  - Roberto Masciullo
AU  - Claudio Staedler
AU  - Claudio Gobbi
AU  - Chiara Zecca
PY  - 2026
JO  - Journal of Neurology
DO  - 10.1007/s00415-026-14099-z
UR  - https://doi.org/10.1007/s00415-026-14099-z
ER  - 

APA

Bellotti, A., Noseda, R., Masciullo, R., Staedler, C., Gobbi, C., & Zecca, C. (2026). Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease. Journal of Neurology. https://doi.org/10.1007/s00415-026-14099-z

Source records